Navigation Links
Renovis Reports Third Quarter 2007 Financial Results
Date:11/6/2007

70 in the comparable periods in 2006.

At September 30, 2007, Renovis had $85.7 million in cash, cash equivalents and short-term investments.

Highlights

"The September 19 announcement of a definitive merger agreement with Evotec highlighted the quarter. By combining our team and late-stage preclinical assets with the capable management and clinical pipeline at Evotec, we believe we have provided investors a value-enhancing strategy for their holdings. Together, Evotec and Renovis offer investors a broad but focused pipeline, a strong financial foundation, and momentum in a late-stage preclinical pipeline that has the potential to bring important pain and inflammation products to the market," noted John Walker, Executive Chairman.

2007 Financial Guidance

Financial projections involve a high level of uncertainty due, among many factors, to the variability involved in predicting requirements of drug discovery and clinical development activities and the potential for Renovis to enter into new licensing agreements or strategic collaborations. We plan to update financial guidance for 2007, as necessary, when we release results for each quarter or upon the announcement of material corporate events.

For the year ending December 31, 2007, the Company continues to anticipate:

-- total contract revenue from existing agreements of $9.0 million to

$10.0 million; and

-- total operating expenses of $28.0 million to $32.0 million, excluding

non-cash, stock-based compensation to be recognized in accordance with

SFAS No. 123R, $1.0 million in restructuring expense and merger costs

related to our proposed merger with Evotec.

Option Grants Under NASDAQ Marketplace Rule 4350

In accordance with NASDAQ Marketplace Rule 4350, Renovis granted employment inducement stock options to five non-executive employees hired between August 7, 2007 and November 6, 2007 to support the Company's research and d
'/>"/>

SOURCE Renovis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Renovis to Present at CIBC World Markets Healthcare Conference
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Toronto, Canada (PRWEB) September 16, 2014 ... Estate, the Toronto affiliate of ITRA Global, new development ... With the Toronto city council approving another 755 storeys ... buildings), it appears construction cranes will be dominating the ... that seems to have an unquenchable thirst for new ...
(Date:9/15/2014)... EnGeneIC, Ltd. , an emerging ... cancer through the targeted delivery of therapeutic agents ... the Asbestos Disease Research Institute (ADRI), it has ... (NSW) Premier,s Award for Excellence in Translational Cancer ... that will be involved in the clinical trial, ...
(Date:9/15/2014)... researchers led by Northeastern University has developed a ... and a variety of nanocarbon structures in carbon ... scalable, which will allow the researchers to tailor ... in applications ranging from electronic devices to CNT-reinforced ... sports equipment. , Their findings were published in ...
(Date:9/15/2014)... AUSTIN, Texas , Sept. 15, 2014 The ... changes in climate, says a new article published by the ... Ahmed , PhD, on climate change and its effects on ... part of an extensive study conducted by Dr. Ahmed in ... China and has implications for the future ...
Breaking Biology Technology:ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 2ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 3EnGeneIC Named a Recipient of the Cancer Institute NSW Premier's Award for Excellence in Translational Cancer Research 2EnGeneIC Named a Recipient of the Cancer Institute NSW Premier's Award for Excellence in Translational Cancer Research 3Northeastern University Researchers Develop Novel Method for Working with Nanotubes 2Tea Taste and Quality Affected by Climate Change 2Tea Taste and Quality Affected by Climate Change 3Tea Taste and Quality Affected by Climate Change 4
... Evaluating KRX-0401 in Advanced Renal Cell Carcinoma, Colorectal Cancer ... NEW YORK, May 18 Keryx Biopharmaceuticals, Inc. (Nasdaq: ... on KRX-0401 (Perifosine), the Company,s Akt-inhibitor for cancer, were ... the 45th Annual Meeting of the American Society of ...
... Elderly and Patients With Movement Disorders at Home and ... Millions of people in the US have diseases ... many of them, traditional walking aids such as canes ... to walk normally and live independently.Now there,s a high-tech ...
... Scientific Advisory Board Member Recognized for Development of Statistical ... Wong, Professor of Statistics and of Health Research & ... to the US National Academy of Sciences. Election ... the highest honors that can be accorded to a ...
Cached Biology Technology:Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology 2Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology 3Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology 4Now Available: State-of-the-Art Gait Training Device to Help Millions Walk More Normally Again 2Professor Wing Wong Elected to the National Academy of Sciences 2
(Date:9/16/2014)... impact that spelled doom for the dinosaurs 66 million ... to a much greater extent than their deciduous peers, ... results are published in the journal PLOS Biology ... trove of thousands of fossilized leaves of angiosperms ... able to reconstruct the ecology of a diverse plant ...
(Date:9/16/2014)... vessel returned to Spain culminating the around the world ... picture of how the global ocean works and what ... from the atmosphere is not limited to coastal areas, ... the planet, and it is already affecting the ocean ... in CSIC Residence for Researchers in Barcelona, in a ...
(Date:9/16/2014)... CRG researchers shed ... Journal of Cell Biology describes how Topo 2 disentangles ... At this very moment thousands of our body,s cells are ... body repairs damaged tissues and regenerates others like skin and ... during which the cell duplicates its genetic material and separates ...
Breaking Biology News(10 mins):Meteorite that doomed dinosaurs remade forests 2Meteorite that doomed dinosaurs remade forests 3Meteorite that doomed dinosaurs remade forests 4The Malaspina Expedition confirms that pollution reaches even the most remote areas of the ocean 2The Malaspina Expedition confirms that pollution reaches even the most remote areas of the ocean 3Unraveling cell division 2Unraveling cell division 3
... microarray that holds 1,200 individual cultures of fungi or ... to a study published in mBio , the ... Scientists at the University of Texas at ... Research at Fort Sam Houston have developed a microarray ...
... 24, 2013 /PRNewswire-iReach/ -- TabletKiosk®, a leading manufacturer ... today announces a new collaboration with SensoMotoric Instruments ... control, guidance and registration technology, to cooperatively develop ... PC with market ready eye tracking integration. ...
... This news release is available in ... Parentage-based tagging (PBT) is an emerging genetic-based fish tagging method ... approach to stock identification because the parents, not the offspring, ... This method provides the same information as traditional physical tags ...
Cached Biology News:New palm-sized microarray technique grows 1,200 individual cultures of microbes 2TabletKiosk and SMI Collaborate to Produce the Sahara EyeSlate 2TabletKiosk and SMI Collaborate to Produce the Sahara EyeSlate 3It's all in the genes -- including the tracking device 2
... The steadylite plus assay ... High assay sensitivity, Designed for ... Suitable for higher density microplates ... plates, Odor free, Convenient storage ...
Sf21 cells derived from Spodoptera frugiperda ovarian cells are recommended for high-level production of recombinant proteins. Higher expression levels of some proteins are seen due to the larger ce...
... assay system offers the following ... for batch-processing systems, Long lasting ... microplates such as 384-well and ... storage conditions ( 2 - ...
Sf9 cells derived from Spodoptera frugiperda ovarian cells (Sf21 cells) are commonly used to isolate and propagate recombinant AcMNPV viral stocks and to produce recombinant proteins....
Biology Products: